As of June 17, 2025, Gene One Life Science Inc (011000.KS) reports a Gross Margin of -30.43%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Gene One Life Science Inc's Gross Margin
Over recent years, Gene One Life Science Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | -30.43% |
| 2023-12-31 | -19.30% |
| 2022-12-31 | 19.16% |
| 2021-12-31 | 22.63% |
| 2020-12-31 | 27.50% |
This gradual decrease highlights how Gene One Life Science Inc manages its operational efficiency and pricing power over time.
Comparing Gene One Life Science Inc's Gross Margin to Peers
To better understand Gene One Life Science Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Gene One Life Science Inc (011000.KS) | -30.43% |
| Cell Biotech Co Ltd (049960.KQ) | 72.25% |
| Isu Abxis Co Ltd (086890.KQ) | 71.93% |
| PharmaResearch Co Ltd (214450.KQ) | 71.76% |
| Tego Science Inc (191420.KQ) | 70.67% |
| Hans Biomed Corp (042520.KQ) | 63.78% |
Compared to its competitors, Gene One Life Science Inc's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.